Treatment for Locally Advanced Pancreatic Cancer: Optimizing patient selection and response assessment
Leonard Seelen, Heelkunde Opleiding, MS CGO, Hjalmar C. van Santvoort et autres
Pancreatic ductal adenocarcinoma (PDAC) remains a challenging disease with a persistently poor prognosis despite small advances in oncological care. In the Netherlands, approximately 3000 new cases of pancreatic cancer are diagnosed each year of whom 30% of patients present with LAPC. Systemic …
0 citations
Utrecht University Repository (Utrecht University)